IO Clinical Research: the Good, the Bad, the Ugly
Sunday, January 13, 2013
One of the exciting developments in IO research has been the investment by industry in prospective clinical trials to help define best practice in the care of our patients. Nordion, Merit/Biosphere, Sirtex, BTG/Biocompatibles, Siemens, and Delcath all sponsor multicenter Phase 2 and 3 trials......